Results 241 to 250 of about 37,295 (269)
Some of the next articles are maybe not open access.

Pseudomalabsorption of Levothyroxine

JAMA: The Journal of the American Medical Association, 1991
--The issue of patient compliance with pharmacological therapy vs malabsorption of medication was explored in the context of persistent hypothyroidism despite the administration of large doses of levothyroxine sodium.--Retrospective case series.--Referred care in two large tertiary care centers.--Four patients, seen within two decades, with clinical ...
Bruce D. Weintraub   +3 more
openaire   +3 more sources

Levothyroxine Poisoning

Pediatrics, 1985
To the Editor.— We read the recent report by Lehrner and Weir1 of acute levothyroxine ingestions with concern. Advocacy of an aggressive approach disregards their own cases as well as the medical literature,2-5 Which contains at least seven cases of acute excessive ingestion of levothyroxine (five of which were overlooked by the authors).
J D, White, T L, Litovitz
openaire   +2 more sources

Potency of Levothyroxine Products

JAMA: The Journal of the American Medical Association, 1984
Recently, the company that manufactures the levothyroxine product that we use most often in our practice switched to high-pressure liquid chromotography (HPLC) to monitor their product. As a result, the brand name product now contains 100% of expected potency as determined in our laboratory by radioimmunoassay.
Sheldon S. Stoffer, Walter E. Szpunar
openaire   +3 more sources

Unusual Malabsorption of Levothyroxine

Thyroid, 2000
We report a 50-year-old woman, with overt hypothyroidism undergoing thyrotropin (TSH)-stimulating hormone suppressive levothyroxine (LT4) treatment after subtotal thyroidectomy. At her first visit to our department, the laboratory results revealed a borderline low free thyroxine (FT4) level accompanied by a clearly elevated TSH level.
Peter Mikosch   +6 more
openaire   +3 more sources

Replacement Doses of Levothyroxine

Annals of Internal Medicine, 1982
Excerpt To the editor: We read with interest the article by Rosenbaum and Barzel on levothyroxine replacement doses for primary hypothyroidism (1).
openaire   +3 more sources

Delayed Intestinal Absorption of Levothyroxine

Thyroid, 1995
We report four female patients with nodular goiter (in two of the four due to Hashimoto's thyroiditis) and one male patient with frank hypothyroidism due to Hashimoto's thyroiditis in whom TSH-suppressive or replacement L-T4 therapy failed to suppress or, respectively, normalize serum TSH.
BENVENGA, Salvatore   +4 more
openaire   +4 more sources

Interaction Between Rifampin and Levothyroxine

Southern Medical Journal, 1999
Rifampin is a potent inducer of hepatic enzymes and is well documented to cause many clinically significant drug interactions. Studies in normal volunteers have shown its ability to decrease circulating levels of thyroid hormone, while having no effect on thyroid-stimulating hormone (TSH).
John Norwood   +2 more
openaire   +2 more sources

Acute overdose of levothyroxine in a dog

Journal of the American Veterinary Medical Association, 1992
An overdose of up to 850 levothyroxine sodium tablets (0.2 mg) in a healthy 6-year-old 16.8-kg dog induced an episode of vomiting and hippus within 9 hours of ingestion. The dog was treated with activated charcoal and saline (magnesium sulfate) cathartic. Initially the serum concentration of thyroxine (T4) 4,900.9 nmol/L.
S R, Hansen, S P, Timmons, D C, Dorman
openaire   +2 more sources

Levothyroxine Poisoning – Symptoms and Clinical Outcome [PDF]

open access: possibleBasic & Clinical Pharmacology & Toxicology, 2015
AbstractLevothyroxine (LT), T4, poisoning is rarely associated with a severe outcome. However, cases with significant complications have been reported. The aim of this study was to identify factors associated with symptoms of poisoning including late‐onset symptoms.
Birgitte Nygaard   +5 more
openaire   +4 more sources

Tablet Formulation of Levothyroxine Is Absorbed Less Well Than Powdered Levothyroxine

Thyroid, 2003
The comparative bioavailability of oral doses of levothyroxine (LT(4)) formulation taken as tablets, after being crushed, or chewed before swallowing has not been well studied. Three patients with hypothyroidism who showed persistent elevation of serum thyrotropin (TSH) despite taking 200, 150, and 125 microg of LT(4) tablets per day are presented ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy